Source: Annual Congress 2003 - Cystic fibrosis bronchiectasis, respiratory viral infections and infection in asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Mulrennan, J. C. Ojoo, J. A. Kastelik, A. H. Morice, A. E. Redington (Cottingham, United Kingdom). Airway acidification and exhaled nitric oxide in cystic fibrosis. Eur Respir J 2003; 22: Suppl. 45, 3210

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Fractional exhaled nitric oxide in bronchiectasis Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Bronchial and alveolar components of exhaled nitric oxide and their relationship Source: Eur Respir J 2012; 39: 1258-1261 Year: 2012 Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Applications of exhaled and nasal nitric oxide in airway diseases Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Fractional exhaled nitric oxide in pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Exhaled nitric oxide in mustard airway disease Source: International Congress 2018 – Occupational and environmental lung diseases: influence on the airway and interstitium Year: 2018 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma Source: Eur Respir J 2016; 48: 242-244 Year: 2016